A
Case-Based Approach to Parkinson’s Disease:
Identifying, Diagnosing, and Initiating Treatment
The identification and treatment
of Parkinson’s disease can be complicated.
This activity includes cases to illustrate proper
diagnostic criteria for Parkinson’s disease
and its associated nonmotor symptoms. In addition,
a discussion of how initial treatment might affect
nonmotor symptoms and later stages of the disease
will be discussed.
Practice
Pearls: Updates in Antimicrobial Medicine
This informative program will provide
a multi-disciplinary update on antimicrobial medicine
for the emergency physician. Antimicrobial treatment
of both community acquired pneumonia and complicated
intra-abdominal infection will be discussed. Specifically,
updates in treatment guidelines will be covered
in light of the latest Medicare quality indicators
and unique needs of emergency physicians.
Next
Steps in Alzheimer’s Disease: Improvements
in Diagnosis and Treatment
This supplement is based on the
proceedings from a satellite symposium on Alzheimer’s
disease (AD) at the 2007 AAGP annual conference.
The current understanding of mild cognitive impairment
(MCI) and its clinical implications are discussed.
Potential biomarkers for diagnosing MCI and AD
are also presented. The final section of the supplement
reviews disease-modifying strategies that are
currently in development.
Staying
Current in Community-Acquired Pneumonia
This symposium features a discussion
of the most recent IDSA/ATS guidelines on community-acquired
pneumonia (CAP) and covers the topic of trends
toward antimicrobial resistance in the United
States and Canada. In addition, recent data regarding
the efficacy of fluoroquinolone monotherapy relative
to combination antimicrobial therapy are presented.
The merits of using monotherapy in all CAP patients,
including those who are elderly or frail, are
considered.
Comprehensive
Management of Patients With Complicated Intra-Abdominal
Infections
Complicated intra-abdominal infections
(cIAI) are a major surgical and medical challenge.
This educational supplement, which is composed
of 3 articles, describes several aspects of the
management of cIAI. The supplement discusses resuscitative
measures and pharmacologic and nonpharmacologic
therapeutic tools that are recommended in current
guidelines. In addition, the unintended damage
that may occur during the treatment of cIAI is
highlighted.
EXPIRED CME/CE ACTIVITIES
The following
activities are no longer available for credit; however,
we believe the content to be important and hope
you will enjoy reviewing them.
American
Journal of Medicine Osteoporosis Journal Supplement
“Improving
Compliance and Persistence with Osteoporosis Therapies”
This series of articles discusses
challenges and potential solutions in the prevention
and treatment of osteoporosis. Topics include:
the prevention of bone fracture, medication compliance
with bisphosphonate treatment, and methods of
monitoring osteoporosis therapy, including bone
mineral density and bone turnover markers.
ASPIRE
(Acid Suppression Pharmacotherapy in the ICU: Re-evaluating
the Evidence)
ASPIRE is an educational initiative
intended to inform physicians, pharmacists, and
allied healthcare professionals of the latest
therapeutic approaches and guidelines for the
management of patients hospitalized with conditions
such as peptic ulcer rebleeding and stress-related
mucosal disease. These conditions affect the majority
of the 4 million patients presenting to the ICU
each year.
High-Risk
Cardiovascular Disease Website
The High-Risk Cardiovascular Disease
Website uses a multifaceted approach to equip
physicians with tools to better manage their high-risk
and special-population patients, ensuring optimal
clinical outcomes and improving the process of
cardiovascular patient care.
Strangers
in the Night: Case-based Learnings on Nighttime
and Supraesophageal GERD
This activity reviews the impact
that nighttime GERD has on work productivity and
quality of life. It
provides a critical review of the evidence indicating
that nighttime reflux contributes to supraesophageal
symptoms. Finally, the relationship between
nighttime GERD and sleep are explored.
OBG
Management
Overactive Bladder (OAB) is a condition
that significantly impairs quality of life. This
activity discusses the treatments available for
OAB and the risks involved with the use of anticholinergic
agents when treating this condition. Physicians
must be aware of the potentially serious implications
of anticholinergic therapy, particularly when
treating older, more at risk patients.
Medscape
This case-based activity discusses
the important considerations that must be made
when choosing therapy for Overactive Bladder (OAB).
Practitioners will be made aware of the important
components of OAB diagnosis and management. In
addition to nonpharmacologic strategies, the current
FDA-approved agents will be considered.
|
